Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
S100PBP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
USP21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
UBR7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IRX5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
TRAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC58 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INTS4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFNGR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ETV3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNTB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERTAD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM50A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EGR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR6756 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NLK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF103 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on